Recombinant Human V-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (avian)
Cat.No. : | ERBB3-2514H |
Product Overview : | RecombinantHuman V-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (avian)protein, was expressed in Human HEK293 cells and purified by SDS-PAGE andCoomassie blue staining |
- Specification
- Gene Information
- Related Products
Cat. No. : | ERBB3-2514H |
Description : | This gene encodes amember of the epidermal growth factor receptor (EGFR) family of receptortyrosine kinases. This membrane-bound protein has a neuregulin binding domainbut not an active kinase domain. It therefore can bind this ligand but notconvey the signal into the cell through protein phosphorylation. However, itdoes form heterodimers with other EGF receptor family members which do havekinase activity. Heterodimerization leads to the activation of pathways whichlead to cell proliferation or differentiation. Amplification of this geneand/or overexpression of its protein have been reported in numerous cancers,including prostate, bladder, and breast tumors. Alternate transcriptionalsplice variants encoding different isoforms have been characterized. Oneisoform lacks the intermembrane region and is secreted outside the cell. Thisform acts to modulate the activity of the membrane-bound form. Additionalsplice variants have also been reported, but they have not been thoroughlycharacterized. |
Host : | HumanHEK293 cells |
Preparation : | HEK293T cells weretransiently transfected with MegaTran Transfection Reagent and TrueORF cDNAplasmid. Transfected cells were cultured for 48-72 hrs before collection. Thecells were lysed in modified RIPA buffer (25mM Tris-HCl pH7.6, 150mM NaCl, 1%NP-40, 1mM EDTA, 1xProteinase inhibitor cocktail mix, 1mM PMSF and 1mMNa3VO4), and then centrifuged to clarify the lysate. Recombinant proteinswere purified through anti-DDK affinity columns. Protein concentration wasmeasured by BCA kit |
Molecular Weight : | 146 kDa |
Purity : | > 80% asdetermined by SDS-PAGE and Coomassie blue staining |
Concentration : | > 50 ug/ml asdetermined by BCA |
Buffer : | 10% glycerol, 100 mMglycine, 25 mM Tris-HCl, pH 7.3 |
Storage : | Store at -80C. Avoidrepeated freeze-thaw cycles. Stable for 3 months from receipt of productsunder proper storage and handling conditions |
Gene Name : | ERBB3v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) [ Homosapiens ] |
Official Symbol : | ERBB3 |
Synonyms : | ERBB3; v-erb-b2 erythroblasticleukemia viral oncogene homolog 3 (avian); LCCS2, lethal congenitalcontracture syndrome 2; receptor tyrosine-protein kinase erbB-3; HER3 |
Gene ID : | 2065 |
mRNA Refseq : | NM_001982 |
Protein Refseq : | NP_001973 |
MIM : | 190151 |
Uniprot ID : | P21860 |
Chromosome Location : | 12q13 |
Pathway : | Calcium signaling pathway,organism-specific biosystem; Calcium signaling pathway, conserved biosystem;Endocytosis, organism-specific biosystem; Endocytosis, conserved biosystem;ErbB receptor signaling network, organism-specific biosystem; |
Function : | ATP binding; growth factor binding;growth factor binding; nucleotide binding; protein binding |
Products Types
◆ Recombinant Protein | ||
ERBB3-209H | Active Recombinant Human ERBB3(Met1-Thr643), His-tagged | +Inquiry |
ERBB3-238H | Recombinant Human ERBB3 Protein, Strep-tagged | +Inquiry |
ERBB3-28H | Active Recombinant Human ERBB3 Protein (Ser20-Gly538), C-6×His tagged | +Inquiry |
ERBB3-235H | Recombinant Human ERBB3 Protein, His-tagged, Biotinylated | +Inquiry |
ERBB3-23H | Active Recombinant Human ERBB3 Protein | +Inquiry |
◆ Lysates | ||
ERBB3-1721RCL | Recombinant Rhesus ERBB3 cell lysate | +Inquiry |
ERBB3-430HCL | Recombinant Human ERBB3 cell lysate | +Inquiry |
ERBB3-1765MCL | Recombinant Mouse ERBB3 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionPotential side effects may include skin rash, diarrhea, and cardiovascular issues, as seen with other drugs targeting the EGFR family.
ERBB3 activation has been associated with resistance to some targeted therapies, such as EGFR inhibitors, making it a challenging target in cancer treatment.
ERBB3 can form heterodimers with other EGFR family members, such as EGFR and HER2, leading to the activation of downstream signaling pathways.
Yes, elevated ERBB3 expression has been linked to poor prognosis in certain cancers, serving as a potential biomarker for patient outcomes.
ERBB3 overexpression is frequently observed in breast, ovarian, and gastric cancers, among others.
Customer Reviews (3)
Write a reviewTheir expert team has been instrumental in addressing any challenges or concerns I have encountered during my experiments.
Their prompt and comprehensive assistance has proven invaluable in overcoming obstacles and optimizing my experimental protocols.
The ERBB3 protein boasts remarkable stability, allowing for extended storage without compromising its integrity or performance.
Ask a Question for All ERBB3 Products
Required fields are marked with *
My Review for All ERBB3 Products
Required fields are marked with *
Inquiry Basket